click below
click below
Normal Size Small Size show me how
Endocrine I-III
| Generic Name | Brand Name | Pharmacological Category | Common Indications |
|---|---|---|---|
| metformin (PO) | Glucophage Glucophage XR | Biguanide | Type 2 DM, PCOS |
| saxagliptin (PO) | Onglyzza | Dipeptidyl peptidase (DPP-4) inhibitor | Type 2 DM |
| sitagliptin (PO) | Januvia | Dipeptidyl peptidase (DPP-4) inhibitor | Type 2 DM |
| liraglutide (subcutaneous) | Victoza, Saxenda | Glucagon-like peptide-1 (GLP-1) receptor agonist | Type 2 DM, chronic weight management |
| insulin NPH (subcutaneous) | Humulin N Novolin N | Insulin, intermediate acting | Type 1 DM, type 2 DM |
| insulin detemir (subcutaneous) | Levemir | Insulin, long acting | Type 1 DM, type 2 DM |
| insulin glargine (subcutaneous) | Lantus, Toujeo | Insulin, long acting | Type 1 DM, type 2 DM |
| insulin aspart (subcutaneous) | Novolog | Insulin, rapid acting | Type 1 DM, type 2 DM |
| insulin lispro (subcutaneous) | Humalog | Insulin, rapid acting | Type 1 DM, type 2 DM |
| insulin regular (subcutaneous, IV) | Humalin R Novolin R | Insulin, short-acting | Type 1 DM, type 2 DM, DKA |
| glimepiride (PO) | Amaryl | Sulfonylurea | Type 2 DM |
| glipizide (PO) | Glucotrol Glucotrol XL | Sulfonylurea | Type 2 DM |
| glyburide (PO) | Glynase | Sulfonylurea | Type 2 SM |
| pioglitazone (PO) | Actos | Thiazolidinedione (TZD) | Type 2 DM |
| levothyroxine (PO, IV) | Synthroid, Levoxyl | Thyroid product | Hypothyroidism |
| thyroid desiccated (PO) | Armour Thyroid | Thyroid product | Hypothyroidism |
| sitagliptin and metformin (PO) | Janumet Janumet XR | Dipeptidyl peptidase (DPP-4) inhibitor Biguanide | Type 2 DM, PCOS |
| drospirenone and ethinyl estradiol (PO) | Various | Contraceptive | Contraception, acne |
| levonorgestrel and ethinyl estradiol (monophasic) (PO) | Various | Contraceptive | Contraception, acne |
| norethindrone and ethinyl estradiol (1/35) (PO) | Various | Contraceptive | Contraception, acne |
| norethindrone, ethinyl estradiol, and ferrous fumarate (PO) | Various | Contraceptive | Contraception, acne |
| norgestimate and ethinyl estradiol (PO) | Various | Contraceptive | Contraception, acne |
| norgestimate and ethinyl estradiol (triphasic) (PO) | Various | Contraceptive | Contraception, acne |
| norgestrel and ethinyl estradiol (PO) | Various | Contraceptive | Contraception, acne |
| estrogens (conjugated) (PO, topical) | Premarin | Estrogen derivative | Vasomotor symptoms associated with menopause, vaginal atrophy associated with menopause |
| estradiol (transdermal) | Vivelle Dot | Estrogen derivative | Vasomotor symptoms associated with menopause, vaginal atrophy associated with menopause |
| medroxyprogesterone (PO) | Provera | Progestin | Abnormal uterine bleeding, secondary amenorrhea |
| estrogens (conjugated) and medroxyprogesterone (PO) | Prempro, Premphase | Estrogen derivative Progestin | Vasomotor symptoms associated with menopause, vaginal atrophy associated with menopause Abnormal uterine bleeding, secondary amenorrhea |
| testosterone gel (topical) | AndroGel, Fortesta, Vogelxo | Androgen | Hypogonadism |
| alendronate (PO) | Fosamax | Bisphosphonate | Osteoporosis |
| ibandronate (PO) | Boniva | Bisphosphonate | Osteoporosis |
| raloxifene (PO) | Evista | Selective estrogen receptor modulator (SERM) | Osteoporosis, breast cancer prevention |
| sildenafil (PO) | Viagra, Revatio | Phosphodiesterase-5-enzyme (PDE5) inhibitor | ED, PAH |
| tadalafil (PO) | Cialis | Phosphodiesterase-5-enzyme (PDE5) inhibitor | ED, BPH |
| oxytocin (IV) | Pitocin | Oxytocic agent | Labor induction, post-partum uterine bleeding |